MIKAYLA HERONIMUS: Open Payments
NPI 1205460862 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 13 payments from 8 companies in 2025. Trend: 2023 $205 · 2024 $218 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $117 |
| Amgen Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Medtronic, Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: FABRAZYME, LifeVest, REPATHA, Kerendia, CAMZYOS, MICRA, BodyGuardian, VYNDAQEL.
Industry payments across SD — which companies pay providers there.
